The GLOW Blend is a three-compound peptide stack combining GHK-Cu (copper peptide for collagen synthesis and gene expression modulation), TB-500 (Thymosin Beta-4 fragment for cell migration), and BPC-157 (gastric pentadecapeptide for angiogenesis). Designed for aesthetic and skin regeneration research, it targets the major pathways involved in tissue remodelling and dermal renewal.
The GLOW Blend combines three peptides with complementary mechanisms for tissue remodelling and dermal regeneration research.
GHK-Cu is the primary aesthetic-focused component. Its copper ion delivery supports metalloenzymes critical for skin structure — lysyl oxidase for collagen and elastin crosslinking, and superoxide dismutase for antioxidant defence. The GHK peptide sequence modulates over 4,000 genes, with particular relevance to collagen type I and III synthesis, glycosaminoglycan production, and extracellular matrix remodelling. GHK-Cu has been studied in wound healing and skin ageing models for increasing dermal thickness and improving skin mechanical properties.
TB-500 contributes cell migration and proliferation through G-actin sequestration, driving fibroblast and keratinocyte migration to sites of tissue turnover. In dermal models, Thymosin Beta-4 has been shown to accelerate wound closure and upregulate extracellular matrix proteins including laminin and fibronectin that provide structural scaffolding for skin renewal.
BPC-157 provides the vascular component through eNOS upregulation and angiogenesis promotion. In skin and wound models, adequate vascularisation is essential for delivering nutrients and oxygen to regenerating tissue. BPC-157's additional growth factor modulation (VEGF, EGF receptor) supports the proliferative phase of tissue repair.
The GLOW Blend differs from the KLOW Blend in that it omits KPV (the anti-inflammatory tripeptide), focusing specifically on the regenerative and remodelling mechanisms most relevant to aesthetic and skin research. As with all multi-compound blends, published data on the specific combination is not available — the formulation is based on complementary individual compound mechanisms.
GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration
Pickart L, Vasquez-Soltero JM, Margolina A. · BioMed Research International (2015)
Comprehensive review of GHK-Cu's skin regeneration effects, including gene expression modulation, collagen synthesis stimulation, and antioxidant activity relevant to aesthetic applications.
DOI: 10.1155/2015/648108The actin binding site on thymosin β4 promotes angiogenesis
Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. · FASEB Journal (2003)
Demonstrated the pro-angiogenic activity of Thymosin Beta-4 (parent protein of TB-500), linking actin regulation to blood vessel formation relevant to skin repair.
DOI: 10.1096/fj.03-0291fjeNovel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract healing
Sikiric P, Rucman R, Turkovic B, et al. · Current Pharmaceutical Design (2018)
Detailed BPC-157's vascular recruitment mechanisms including collateral vessel formation and endothelial cell proliferation, supporting the angiogenic component of the GLOW Blend.
DOI: 10.2174/1381612824666180515125056A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices
Arul V, Kartha R, Jayakumar R. · Life Sciences (2007)
Demonstrated accelerated wound healing with GHK-Cu in a diabetic model, including enhanced collagen deposition and angiogenesis — supporting the combination rationale of the GLOW Blend.
DOI: 10.1016/j.lfs.2006.09.018All three peptides are co-lyophilised. The reconstituted solution will have a slight blue-green tint from the copper in GHK-Cu — this is normal and expected. Direct bacteriostatic water along the vial wall and allow full dissolution. Do not shake.
Use reconstitution calculatorLyophilised: store at or below 5 °C for up to 12 months. Reconstituted: refrigerate at 2–8 °C and use within 30 days. Protect from light.
The GLOW Blend contains three peptides (GHK-Cu, TB-500, BPC-157) while the KLOW Blend adds a fourth — KPV, an anti-inflammatory tripeptide. The GLOW Blend focuses on regenerative and remodelling mechanisms for aesthetic research, while the KLOW Blend adds explicit anti-inflammatory pathway targeting.
GHK-Cu modulates the expression of over 4,000 genes, with particular effects on collagen type I and III synthesis, elastin production, and extracellular matrix remodelling. These pathways are directly relevant to skin structure and aesthetics. Its copper delivery also supports lysyl oxidase, the enzyme responsible for collagen and elastin crosslinking.
The blue-green colour is due to the copper (II) ion complexed with the GHK peptide. This is normal and expected. A colourless solution would indicate copper dissociation from the peptide complex.
No. Published research is available for each individual constituent compound (GHK-Cu, TB-500, BPC-157), but not for the specific three-compound combination. The blend formulation is based on complementary mechanisms targeting different phases of tissue remodelling and regeneration.
For research and laboratory purposes only. Not for human use. These statements have not been evaluated by the Therapeutic Goods Administration (TGA). This product is not intended to diagnose, treat, cure, or prevent any disease.
